Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease.

ABSTRACT:

SUBMITTER: Koch RL 

PROVIDER: S-EPMC11729804 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature